Evaluation of Neonatal Screening Programs for Tyrosinemia Type 1 Worldwide

Eitemau Tebyg

• Evaluation of Neonatal Screening Programs for Tyrosinemia Type 1 Worldwide
  gan: Allysa M. Kuypers, et al.
  Cyhoeddwyd: (2024-12-01)
• Evaluation of the Performance of Newborn Screening for Tyrosinemia Type 1 in The Netherlands: Suggestions for Improvements Using Additional Biomarkers in Addition to Succinylacetone
  gan: Marelle J. Bouva, et al.
  Cyhoeddwyd: (2025-05-01)
• Comment on Dijkstra et al. A False-Negative Newborn Screen for Tyrosinemia Type 1—Need for Re-Evaluation of Newborn Screening with Succinylacetone. <i>Int. J. Neonatal Screen.</i> 2023, <i>9</i>, 66
  gan: Marelle J. Bouva, et al.
  Cyhoeddwyd: (2024-09-01)
• Reply to Bouva et al. Comment on “Dijkstra et al. A False-Negative Newborn Screen for Tyrosinemia Type 1—Need for Re-Evaluation of Newborn Screening with Succinylacetone. <i>Int. J. Neonatal Screen.</i> 2023, <i>9</i>, 66”
  gan: Allysa M. Dijkstra, et al.
  Cyhoeddwyd: (2024-09-01)
• A False-Negative Newborn Screen for Tyrosinemia Type 1—Need for Re-Evaluation of Newborn Screening with Succinylacetone
  gan: Allysa M. Dijkstra, et al.
  Cyhoeddwyd: (2023-12-01)